Ellis-Pegler RB - Search Results

1

Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: ellis pegler rb. Clin Endocrinol (Oxf). 2006 Aug;65(2):191-7. doi: 10.1111/j.1365-2265.2006.02572.x. Clin Endocrinol (Oxf). 2006. PMID: 16886959

2

Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: ellis pegler rb. J Clin Endocrinol Metab. 2007 Apr;92(4):1283-8. doi: 10.1210/jc.2006-2216. Epub 2007 Jan 16. J Clin Endocrinol Metab. 2007. PMID: 17227801 Clinical Trial.

3

Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Woodhouse AF, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: ellis pegler rb. Clin Endocrinol (Oxf). 2007 Aug;67(2):270-5. doi: 10.1111/j.1365-2265.2007.02875.x. Epub 2007 Jun 4. Clin Endocrinol (Oxf). 2007. PMID: 17547686

4

Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months.

Bolland MJ, Grey AB, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Callon KE, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: ellis pegler rb. J Bone Miner Res. 2008 Aug;23(8):1304-8. doi: 10.1359/jbmr.080312. J Bone Miner Res. 2008. PMID: 18627266 Free article. Clinical Trial.

5

Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART).

Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: ellis pegler rb. Clin Endocrinol (Oxf). 2012 May;76(5):643-8. doi: 10.1111/j.1365-2265.2011.04274.x. Clin Endocrinol (Oxf). 2012. PMID: 22040002 Clinical Trial.

6

Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men.

Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR. Bolland MJ, et al. Among authors: ellis pegler rb. J Clin Endocrinol Metab. 2012 Jun;97(6):1922-8. doi: 10.1210/jc.2012-1424. Epub 2012 Mar 14. J Clin Endocrinol Metab. 2012. PMID: 22419728 Clinical Trial.

7

Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital.

Upton A, Ellis-Pegler RB, Woodhouse A. Upton A, et al. Among authors: ellis pegler rb. N Z Med J. 2004 Aug 20;117(1200):U1020. N Z Med J. 2004. PMID: 15475990

8

Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.

Thomas M, Rupali P, Woodhouse A, Ellis-Pegler R. Thomas M, et al. Scand J Infect Dis. 2009;41(11-12):862-8. doi: 10.3109/00365540903214256. Scand J Infect Dis. 2009. PMID: 19922070

9

Good outcome in HIV-infected refugees after resettlement in New Zealand: population study.

Nisbet SM, Reeve AM, Ellis-Pegler RB, Woodhouse AF, Ingram RJ, Roberts SA, McAllister SM, Thomas MG. Nisbet SM, et al. Among authors: ellis pegler rb. Intern Med J. 2007 May;37(5):290-4. doi: 10.1111/j.1445-5994.2007.01335.x. Intern Med J. 2007. PMID: 17504275

10

Antiretroviral treatment of HIV infection.

Thomas MG, Ellis-Pegler RB. Thomas MG, et al. N Z Med J. 1995 May 24;108(1000):181-2. N Z Med J. 1995. PMID: 7783984 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters